Meritage Homes
MTH
Taylor Morrison Home
TMHC
Vale SA
VALE
D.R. Horton
DHI
Strategy
MSTR
US Stock MarketDetailed Quotes
DNTH Dianthus Therapeutics
- 20.635
- +0.775+3.90%
Trading Mar 5 10:37 ET
610.73MMarket Cap-9.03P/E (TTM)
21.750High19.790Low26.18KVolume19.790Open19.860Pre Close549.92KTurnover0.20%Turnover RatioLossP/E (Static)29.60MShares33.77052wk High1.81P/B267.34MFloat Cap18.13052wk Low--Dividend TTM12.96MShs Float336.000Historical High--Div YieldTTM9.87%Amplitude5.136Historical Low21.005Avg Price1Lot Size
Dianthus Therapeutics News
Dianthus Therapeutics | 10-Q: Q3 2024 Earnings Report
Dianthus Therapeutics | 10-Q: Quarterly report
Dianthus Therapeutics | 10-Q: Quarterly report
Dianthus Therapeutics | 10-K: FY2023 Annual Report
Dianthus Therapeutics | 10-Q: Quarterly report
Magenta Therapeutics | 10-Q: Q2 2023 Earnings Report
Magenta Therapeutics | 10-Q: Q1 2023 Earnings Report
Magenta Therapeutics | 10-K/A: Annual report (Amendment)
Dianthus Therapeutics | 10-K: FY2022 Annual Report
Magenta Therapeutics | 10-Q: Q3 2022 Earnings Report
Magenta Therapeutics | 8-K: Magenta Therapeutics Reports Third Quarter Financial Results and Recent Program Highlights
Magenta Therapeutics | 10-Q: Q2 2022 Earnings Report
Magenta Therapeutics | 8-K: Magenta Therapeutics Reports Second Quarter Financial Results and Recent Program Highlights
Magenta Therapeutics | 10-Q: Q1 2022 Earnings Report
Magenta Therapeutics | 8-K: Magenta Therapeutics Reports First Quarter Financial Results, Early Clinical Observations from MGTA-117 Clinical Trial and Other Program Highlights
Magenta Therapeutics | 10-K: FY2021 Annual Report
Magenta Therapeutics | 8-K: Magenta Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Program Highlights
Magenta Therapeutics | 10-Q: Q3 2021 Earnings Report
Magenta Therapeutics | 10-Q: Q2 2021 Earnings Report
Magenta Therapeutics | 10-Q: Q1 2021 Earnings Report
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.